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Mammalian circadian clocks restrict cell proliferation to deﬁned
time windows, but the mechanism and consequences of this in-
terrelationship are not fully understood. Previouslywe identiﬁed the
multifunctional nuclear protein NONO as a partner of circadian PE-
RIOD (PER) proteins. Here we show that it also conveys circadian
gating to the cell cycle, a connection surprisingly important for
wound healing in mice. Speciﬁcally, although ﬁbroblasts from
NONO-deﬁcientmice showedapproximatelynormal circadian cycles,
they displayed elevated cell doubling and lower cellular senescence.
At a molecular level, NONO bound to the p16-Ink4A cell cycle check-
point gene and potentiated its circadian activation in a PER protein-
dependent fashion. Loss of either NONO or PER abolished this acti-
vation and circadian expression of p16-Ink4A and eliminated circa-
dian cell cycle gating. In vivo, lack of NONO resulted in defective
wound repair. Because wound healing defects were also seen in
multiple circadian clock-deﬁcientmouse lines, our results therefore
suggest that coupling of the cell cycle to the circadian clock via
NONO may be useful to segregate in temporal fashion cell prolif-
eration from tissue organization.
keratinocyte | p54nrb | RNA-binding protein | paraspeckle protein
The circadian clock adapts organisms to their daily surround-ings both behaviorally and physiologically. In animals, not
only are complex behaviors such as sleep and mood governed by
this oscillator, but also different body functions such as digestion,
circulation, and respiration (1). The basic mechanism of this
clock is cell-autonomous in all studied species possessing a cir-
cadian clock. In mammals, individual clocks in most cells are
synchronized by a brain “master clock” in the suprachiasmatic
nucleus of the hypothalamus to orchestrate all rhythmic physi-
ology (2). On a cellular level, circadian physiology extends even to
processes such as proliferation (3–7), apoptosis (8), and DNA
damage repair (6, 9), which are thought to play important roles in
cancer control (8, 10).
In individual cells, the circadian clock mechanism consists of
oscillating feedback loops of transcription of “core” oscillator genes
and posttranslational modiﬁcations of their protein products that
regulate protein stability, activity, and/or localization. For example,
in mammals the transcription of periods (Per) and cryptochomes
(Cry) are activated by BMAL1:CLOCK heterodimers at cis-
acting elements called E-boxes, and their protein products form
complexes that repress their own transcription (11). We origi-
nally identiﬁed the RNA-binding protein NONO (also called
p54nrb) biochemically as a new member of this circadian tran-
scriptional repressor complex in mice, and mutation of its
orthologNonA in ﬂies resulted in severe attenuation of circadian
rhythmicity (12). However, apart from its interaction with this
circadian repressor complex, NONO’s mechanism of action
within the clock remains unknown.
The mechanism of the cell cycle has been reviewed extensively
elsewhere (13, 14). Rather than having a ﬁxed duration, its period
is tightly regulated by cellular processes via checkpoint proteins
that gate cell cycle progression. The circadian clock is one such
regulatory process, and it has been shown that the circadian clock
can directly time cell division (3, 4), although not necessarily in all
cell types (15, 16). The exact mechanism of this regulation is at
the moment only partially understood and may involve circadian
regulation of cell cycle checkpoint genes like wee1 (3) and p21-
Waf1 (17), or interaction of clock factors with CSK-homologous
kinase 1/2 (CHK1/2) proteins (18, 19). In addition, a limited
number of accessory factors have been assigned roles in both
processes, including the mammalian Timeless protein (TIM),
which interacts with both the circadian CRY2 protein and the cell
cycle CHK1 protein (18), and p54nrb/NONO, which interacts with
proteins involved in DNA damage repair (20, 21).
To understand the role of the NONO protein in the circadian
clock and its relationship to the cell cycle, we created NONO-de-
ﬁcient mice. Although these mice showed only minor circadian
defects (22), circadian gating by the cell cycle was lost in ﬁbroblasts
from these mice, allowing us to probe both the mechanism and the
physiological relevance of the connection between the two pro-
cesses. Our investigations not only uncover a unique role for NONO
in the circadian transcriptional regulation of the p16-Ink4A cell cycle
checkpoint gene, but also suggest that circadian gating of the cell
cycle by NONO plays an unsuspected role in tissue regeneration.
Results
Fibroblasts from Nonogt Mice Show Increased Proliferation and
Decreased Senescence. To better understand the function of
NONO, we used a “genetrapped” embryonic stem cell line (23) to
generate Nonogt mice that completely lack coding Nono transcript
and NONO protein in all tissues tested (Fig. 1A). In addition to
a circadian phenotype of slight period shortening in animal be-
havior and cellular gene expression that was expected from our
previous studies (22), we noticed that the primary ﬁbroblasts taken
to characterize these mice showed more robust division than their
WT counterparts. To quantify this effect, we serially split cells from
WT and Nonogt littermates at a predetermined frequency so that
conﬂuence was not reached and counted cells at each passage.
Nonogt cells indeed showed a markedly increased rate of pop-
ulation doubling relative toWTcells (Fig. 1B). In principle, such an
effect could have arisen either because cells divided faster or be-
cause they reached senescence—the normal postproliferative ar-
rest of cell division in adult tissues—at a lower rate. To examine
senescence, we stained the same cells for senescence-associated
β-galactosidase (SA-βgal) activity (24) at each passage from their
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initial isolation until their complete senescence. Nonogt cells
exhibited a roughly twofold decreased proportion of senescent
cells at every passage (Fig. 1C).
If Nonogt cells had reduced senescence rather than an in-
creased division rate, then fewer cells should remain nondividing
in cultures of equivalent age. We tested this hypothesis by staining
dividing Nonogt and WT cells from the same passage with the
permanent cytoplasmic stain CFSE (carboxyﬂuorescein diacetate,
succinimidyl ester) and then determining dye content by ﬂow
cytometry 4 d later. This dye remains trapped within the cells but
is diluted with each cytokinesis. Hence it provides a quantitative
analysis of the percentage of a cell population that has divided
(25). According to this experiment, all Nonogt cells had divided at
least once, whereas 40% of the WT cells had not divided (Fig.
1D). Reintroduction of NONO into primary Nonogt ﬁbroblasts
via lentiviral transduction slowed division and increased senes-
cence, and addition of NONO to WT cells slowed division even
further (Fig. 1E), conﬁrming the dose-dependent role of NONO
in restraining cell proliferation and pointing to a probable role
for this protein in the cell cycle.
NONO Is a Transcriptional Activator of the p16-INK4A Cell Cycle
Checkpoint Gene. To identify the cell cycle stage at which
NONO has a role, we ﬁxed actively dividing ﬁbroblasts from
WT and Nonogt animals and labeled them with propidium iodide,
a ﬂuorescent DNA-binding dye (26). Subsequent ﬂow cytometry
experiments allowed us to quantify the proportion of cells in
different stages of the cell cycle in each population. Our results
demonstrated a twofold increase of cells in synthesis phase (S
phase) of the cell cycle when NONO was absent. NONO may
thus act as a regulator of exit from the G1 phase (Fig. 2 A and B).
To conﬁrm the effects of NONO upon S phase, we also pulse-
labeled cells with 5-ethynyl-2´-deoxyuridine (EdU), an immuno-
histochemically detectable nucleotide analog incorporated during
DNA replication in S phase. By comparing signals from EdU with
those from propidium iodide in the same cells, we were able to
verify that more cells were indeed in S phase in Nonogt ﬁbroblasts
than in WT ones (Fig. 2C).
In most other systems, NONO has been identiﬁed as a tran-
scriptional cofactor regulating either gene expression or RNA
processing (27). Therefore, we considered it likely that NONO
would exert its effects upon senescence and the cell cycle via
transcriptional regulation of cell cycle genes. On the basis of the
knowledge that NONO acted upon both senescence and the exit
from theG1 phase checkpoint, we considered the p16-Ink4A locus
as a likely target. P16-INK4A has been implicated previously as
a regulator of the mitogen-responsive retinoblastoma pathway
and is one of the key cellular components regulating senescence. It
is known to repress the cyclin D-dependent kinases 4 and 6 (Cdk4
and Cdk6), resulting in a G1 arrest that slows cell division and
promotes senescence (28, 29). To investigate whether the p16-
Ink4A gene is systematically misregulated inNonogt ﬁbroblasts, we
serially passaged cells from both WT and Nonogt mice and ex-
amined the expression levels of p16-Ink4A at each passage. In-
deed, quantitative RT-PCR conﬁrmed that RNA abundance of
p16-Ink4A was systematically down-regulated in Nonogt cells at
each passage, and this change in expression was also reﬂected in
levels of p16-INK4A protein (Fig. 2D).
Because p16-INK4A negatively regulates cell division and posi-
tively regulates senescence, its repression is consistent with the
phenotype observed in Nonogt ﬁbroblasts. As a control, we also
looked at key regulators of other pathways known to control se-
nescence: the DNA damage-responsive p53 locus, and tankyrase,
a downstream regulator of telomere length. No differences were
observed in the levels of tankyrase mRNA between WT and
knockout cells, and p53 was twofold lower, a direction inconsistent
with the phenotype that we observe. In addition, for all known
upstream regulators of p16-Ink4A—the Ets1, Ets2, and Id1 loci—
transcript levels inNonogt cells were unchanged or inconsistent with
the observed down-regulation of p16-Ink4A (Fig. S1 A–E), sup-
porting our hypothesis that p16-Ink4A is a possible direct regulatory
target of NONO. More broadly, we compared expression of cell
cycle genes in Nonogt ﬁbroblasts and their WT counterparts using
a cell cycle gene RT-PCR array, and not surprisingly found tran-
scriptional misregulation ofmultiple other cell cycle genes (Fig. 2E
and Table S1), conﬁrming the effects of NONOupon the cell cycle
in general and the extensive coregulation of cell cycle processes.
To examine further whether NONO might directly regulate the
p16-Ink4A locus transcriptionally, we ﬁrst cotransfected 3T3 ﬁ-
broblast cells with a vector expressing NONO and with a lucifer-
ase reporter for p16-Ink4A promoter activity. The addition of
NONO resulted in a dose-dependent increase up to 14-fold in
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Fig. 1. Mice deﬁcient for NONO show increased cell division and reduced
senescence. (A) NONO RNA expression measured by qPCR in various tissues
taken fromWT (+) and Nonogt animals (gt, not detectable). y axis, expression
levels relative to maximum observed expression. Br, brain; De, dermis; He,
heart; Ki, kidney; Li, liver; Lu, lung (n = 4 animals). (Inset) NONO protein
measured in liver nuclear extract pooled from two representative animals,
as well as in unrelated C57-Bl6J mice (Bl6/J). (B) WT and Nonogt primary
ﬁbroblasts were counted and passaged every 2 d and a constant number of
cells plated to a new dish. Total cell number over time is plotted relative to
initial cell number as population doublings. (Student t test for signiﬁcant
difference of doubling rates, P = 0.05.) (C) Cells from each passage in B were
stained for SA-βgal activity, and the percentages of total cells expressing this
marker were recorded. In this and all subsequent ﬁgures, *P < 0.05 and **P <
0.01 (Student t test). (D) Duplicate nonconﬂuent plates of WT and Nonogt
primary ﬁbroblasts were stained with CFSE and allowed to divide for 4 ad-
ditional days. Dye intensity was then measured by ﬂow cytometry (duplicate
plates of cells in green and blue). As a control, other plates of the same cells
were treated with mitomycin C to inhibit cell division immediately after
staining and then treated in parallel (red). Numbers near curves reﬂect the
percentage overlap between the green/blue curves and red curve. (E) WT
and Nonogt primary ﬁbroblasts were infected with lentivirus WPI (expressing
GFP) or WPI-NONO (expressing NONO) and allowed to proliferate via serial
passaging as in A. Relative cell number for each cell type ±SD was plotted at
each passage (i.e., every 2 d).
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luciferase signal compared with the levels obtained with the re-
porter alone (Fig. 3A), whereas a minimal promoter of p16-Ink4A
(D-141) was not activated, suggesting that NONO functions as
a transcriptional coactivator of the p16-Ink4A locus. By contrast,
transcription of a reporter containing the CMV promoter driving
expression of a hybrid p16-Ink4A-luciferase transcript including
the entire 3′ untranslated region was unchanged (Fig. S2).
Therefore, the effect of NONO on the p16-Ink4A locus is likely
on the transcriptional rather than the posttranscriptional level.
NONO and PER Proteins Bind to the p16-Ink4A Promoter to Direct Its
Circadian Transcription in Vivo. To investigate whether NONO also
acts directly as a transcriptional coactivator of p16-Ink4A in vivo,
we performed ChIP of endogenous NONO protein with the p16-
Ink4A promoter. In murine liver NONO indeed binds to the p16-
Ink4A promoter region (Fig. 3B). As a control, we veriﬁed that
NONO does not bind to the promoter of the Ets1 gene, an up-
stream regulator of p16-Ink4A (Fig. 3C). Importantly, NONO
binds to p16-Ink4A in circadian fashion (Fig. 3B), implying that it
might confer a circadian expression pattern upon this important
cell cycle checkpoint gene.
To test this hypothesis, we examined the expression of p16-
Ink4A directly in mouse liver at different times of day. As pre-
dicted, p16-Ink4A mRNA levels were indeed circadian in their
abundance. In livers from Nonogt mice, this circadian regulation
was lost, and p16-Ink4A transcript levels were nonrhythmic and
low (Fig. 3D). Therefore, circadian regulation by NONO is in-
deed responsible for the circadian gene expression of p16-Ink4A.
We have shown previously that overall NONO transcript and
protein levels are constant throughout the day but that one
particular NONO complex (also containing the PER proteins of
the circadian oscillator) shows circadian variations in abundance
(12). Because the p16-Ink4A promoter was occupied by NONO
BA
Dye intensity (PI)
G1              71.1 +/- 3.0% 
S              4.8 +/- 0.1%
G2/M   22.2 +/- 1.3%
0     50K 100K 150K 200K
0
C
el
ln
um
be
r
2000
1500
1000
500
Dye intensity (PI)
G1               61.3 +/- 3.0%
S               8.8 +/- 1.0%
G2/M    27.6 +/- 3.5%
0         
0     50K 100K 150K 200K
4000
3000
2000
1000
Day 2       4       6       8      10     12 
Wildtype
Nonogt
p1
6-
In
k4
A
 e
xp
re
ss
io
n
2
14
6
10
Wildtype Nonogt
DC
E
Wildtype Nonogt
Wildtype Nonogt
P16-INK4A
Ponceau S
Retinoblastoma
pathway
DNA damage
pathway
Telomere
pathway
Telomere
shortening
ATM
ATR
DNA damage
mdm2 p53
p21cip1
Cyclin E
Cdk2
Oncogenes
Arf
P16-Ink4A
Reactive oxygen
Species (ROS)Mitogens
Cyclin D
Cdk4/6
Rb
C
el
ln
um
be
r
40
30
20
10P
er
ce
nt
ag
e 
of
 c
el
ls
Total EdU incorporation
S-phase enrichment
Fig. 2. NONO-deﬁcient mice show an increased proportion of cells in S phase
and reduced levels of p16-Ink4A. (A) Dividing cultures of primary ﬁbroblasts
from WT mice were stained with propidium iodide and analyzed by ﬂow
cytometry to quantify cellular DNA content. (B) Identical experiments were
performed with Nonogt primary ﬁbroblasts. (C) Percentage of cells in S phase
in dividing cultures of primary ﬁbroblasts from WT and Nonogt mice, as
measured in a separate experiment by pulse-labeling with EdU. (P < 0.001,
difference between genotypes.) Experiment is shown both by total EdU in-
corporation (black bars) and in cells previously sorted for S phase via propi-
dium iodide incorporation (white bars). (D) Total RNA was harvested from
each passage of WT (black squares) and Nonogt (white squares) primary
ﬁbroblasts passaged serially as in Fig 1B. p16-Ink4A transcript levels were
determined by qPCR for each passage. (Expression is shown relative to WT at
day 0, Student t test for signiﬁcant difference of p16 accumulation rates, P =
0.01.) (Inset) Western blot showing levels of p16-INK4A protein from dupli-
cate cultures of dividing WT and Nonogt ﬁbroblasts. To verify equal loading
of protein, Ponceau-S staining of the same blot section is depicted beneath.
(E) Total RNA was harvested from cells under conditions as in A and subjected
to qPCR array analysis. A selection of genes relative to senescence pathways is
shown. Genes regulated in Nonogt cells are shown with gray arrows.
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Fig. 3. NONO binds to the p16-Ink4A promoter to activate transcription. (A,
Left) 3T3 cells were transfected with a luciferase reporter plasmid driven by
0.8 kb of the p16-Ink4A promoter (D-761), as well as indicated amounts of
a plasmid expressing NONO. After 2 d, relative bioluminescence in cellular
extracts was determined (solid bars; data plotted in arbitrary units, signal
from reporter alone = 1). Comparable experiments were performed using
a reporter construct containing only a minimal p16-Ink4A promoter, 0.14kb
(D-141) (open bars). (A, Right) equivalent experiments were performed using
constructs containing deletions of the p16-Ink4A promoter containing the
indicated number of nucleotides upstream of the transcription start site. (B)
Liver chromatin was harvested from WT and Nonogt mice at different times
of day and subjected to immunoprecipitation using an anti-NONO antibody.
Genomic DNA was puriﬁed from the precipitate, and DNA from the p16-
Ink4A promoter was quantiﬁed by qPCR. (C) Bar graph quantifying DNA
from the Ets1 promoter, using the same ChIP reactions as in B. (D) RNA was
harvested from the livers in B, and p16-Ink4A transcript levels were quantiﬁed
by qPCR.
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in circadian fashion, we also tested to determine whether PER
proteins bound there. ChIP analyses from mouse liver demon-
strated that PER2 proteins are present at the p16-Ink4A pro-
moter with the same kinetics as NONO. As expected, no PER2
binding was observed in a per2Brdm1/Brdm1 strain lacking this
protein (Fig. 4A). To determine whether PER proteins were
necessary for the effects of NONO upon the p16-Ink4A pro-
moter, we examined the levels of mRNA from this locus in
per1Brdm1/Brdm1per2Brdm1/Brdm1 mutant mice (henceforth desig-
nated per1/per2mut for simplicity), which lack both proteins (30).
In livers from these mice, the binding of NONO to the p16-Ink4A
promoter was noncircadian and low or absent (Fig. 4B), and p16-
Ink4A transcription itself was also constantly low (Fig. 4C).
These results suggest that a PER–NONO complex is re-
sponsible for the effects of NONO upon the p16-Ink4A pro-
moter. To test this hypothesis explicitly and determine whether
PER proteins are required for NONO to activate p16-Ink4A, we
compared the ability of NONO to activate transcription of a p16-
Ink4A reporter in transient transfections in primary ﬁbroblasts
fromWT and per1/per2mut mice. Transcriptional activation by the
circadian transcriptional activator complex BMAL1/CLOCK was
achieved in both WT and per1/per2mut cells to the same extent
(Fig. 4D). Whereas activation by NONO was observed in WT
cells, no activation was observed in mutant cells (Fig. 4D), in-
dicating that PER proteins are required for NONO activity
(or vice versa).
NONO is Necessary for Circadian Gating of the Cell Cycle. Circadian
transcriptional activation of p16-Ink4A via NONO has predict-
able consequences for cellular physiology. In numerous previous
studies in a variety of contexts, increased expression of p16-
INK4A suppressed cell division, and reduced expression of this
protein augmented it (31). Therefore, if NONO regulates p16-
Ink4a in circadian fashion, we reasoned that NONO might be
one of the unknown regulators that couple the circadian clock to
cell division. To test this hypothesis, we synchronized circadian
rhythms in duplicate plates of WT and Nonogt ﬁbroblasts using
dexamethasone (32). Subsequently these plates were ﬁxed at
different times after synchronization and then stained with pro-
pidium iodide and analyzed by ﬂow cytometry to quantify DNA
content. WT cells showed marked circadian variations in cell di-
vision, with 2.6-fold variation in the proportion of cells in S phase
at midday and midnight (Fig. 5A). In per1/per2mut cells, no such
variations were observed (Fig. 5C). This lack of circadian gating
was equally observed inNonogt cells, which divided throughout the
day at a level equal to the peak of WT cells—consistent with the
derepression of p16-INK4A that normally would negatively reg-
ulate cell division (Fig. 5B). Thus the NONO protein is necessary
for diurnal cell cycle gating in these cells, and its absence likely
leads to a disinhibition of the G1–S transition at speciﬁc circadian
phases due to low levels of p16-INK4A.
Absence of NONO Results in Defective Dermal Wound Healing. De-
spite this dramatic phenotype in primary cells,Nonogtmice develop
normally. Hence, any importance for cell division is probably
conﬁned to adult animals. One situation in which cell division in
adult animals plays an important role is during wound repair.
To test whether NONO is required for normal wound repair,
we wounded the skin of adult WT and Nonogt mice, closed the
resulting full-thickness incisional wound with Steri-strips, and fol-
lowed the wound healing process after 3, 7, 13, and 20 d by histo-
logical wound healing scores. Before wounding, skin structure
appeared indistinguishable among WT and Nonogt animals (Fig.
S3A), and shortly after wounding, scab formation, inﬂammation,
and angiogenesis were normal (Fig. 6A, Left). However, later after
wounding, histological analysis revealed profound alterations in
both dermal and epidermal regeneration. WT wounds exhibited
good reepithelialization and granulation tissue organization.
Granulation tissue consisted of oval or spindle ﬁbroblasts (dark
red) embedded in a dense fascicular system of collagen ﬁbers
(gray; Fig. 6A, Center). The epidermal layer was well structured
and gave, together with the well organized granulation tissue, rise
to new skin that reestablished tissue integrity (Fig. 6A, Right). In
Nonogt mice, immature granulation tissue was characterized by
continued ﬁbroblast proliferation, occupying most of the wound
area (red, Fig. 6A, Right) by day 20. These plumped and round-to-
polyhedral ﬁbroblasts were distributed within a loose matrix with
hardly any collagen production. Similarly, the keratinocyte layer
(stained in pink) was characterized by hyperproliferation and little
epidermal organization (Fig. 6A, Center and Right). Thus, even
as collagen-secreting ﬁbroblasts hyperproliferated in wounded
Nonogt animals, collagen secretion was dramatically diminished
(Fig. 6B). The dividing cells could form only an immature dys-
functional epidermal layer resting on disorganized granulation
tissue, which prevented healing (Fig. 6B and Fig. S3).
Circadian Clock-Deﬁcient Mice Also Show Defects in Wound Healing.
In principle, the defect in wound healing observed in Nonogt mice
might be linked to the circadian cell cycle phenotype described
above, or arise from another unrelated function of NONO. To
distinguish between these hypotheses, we also tested wound
healing in two strains of mice lacking functional circadian clocks:
per1/per2mut mice and bmal1−/− mice. Both strains also showed
defective wound healing. Consistent with the requirement of
PER proteins for NONO activity at the p16-Ink4a promoter, the
per1/per2mut mouse showed a thick layer of immature granulation
tissue that was dominated by an excess of ﬁbroblasts as well as
polymorphonuclear cells. Bmal1−/− mice also showed severe
wound healing defects, although this time marked by lack of
epithelial coverage and a highly disorganized granulation tissue
throughout the observation period. Most wounds in bmal1−/−
mice consisted mainly of an inﬂammatory ﬁbrin clot with hardly
any ﬁbroblast or keratinocyte proliferation (Fig. 7 A and B).
Taken together, our data suggest that a functional circadian
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Fig. 4. Period proteins are necessary for binding and transcriptional acti-
vation of p16-Ink4A by NONO. (A) Liver chromatin was harvested from WT
and per2Brdm1/Brdm1 mice at different times of day and subject to immuno-
precipitation using an anti-PER2 antibody. Genomic DNA was puriﬁed from
the precipitate, and DNA from the p16-Ink4A promoter was quantiﬁed by
qPCR. (B) Bar graph showing ChIP experiments identical to those in A but
using WT and per1/per2mut mice and immunoprecipitated with an anti-
NONO antibody (P ≤ 0.001 for all pairs.) (C) RNA was harvested from the
livers in B, and p16-Ink4A transcript levels were quantiﬁed by qPCR. (D)
Transfection experiments identical to those in Fig. 2C were performed using
primary ﬁbroblasts isolated from WT mice and per1/per2mut mice.
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clock is important for wound healing and that its effects are likely
mediated by NONO.
Discussion
In this article we show that the NONO protein—which we have
identiﬁed previously as a component of the basic circadian oscil-
lator in Drosophila and in mouse cells (12)—plays an equally
important role to gate circadian cell division in ﬁbroblasts. Elim-
ination of NONO entirely abrogated circadian-cell cycle coupling
in ﬁbroblasts, suggesting that NONO serves as a necessary link
between these two processes, at least in these cells. This uncou-
pling allowed us to probe possible functions of this link.
NONO as a Circadian Effector. NONO was initially identiﬁed by its
homology to splicing factors (33) and as aDrosophila factor involved
in courtship songs (34). Since then, diverse studies have described it
as a protein with pleiotropic functions mainly involved in RNA
processing and transport, as well as a transcription factor (27). It has
been implicated in diverse pathways, such as nuclear receptor sig-
naling (35), DNA repair (36, 37), and viral infection (38). Here we
have shown that it can directly activate the p16-Ink4A locus, an
important regulator of the G1 exit checkpoint of the cell cycle. The
detailed mechanism of its coactivator function remains unclear. In
the case of transducer of regulated CREB-binding protein (TORC)-
mediated coactivation by NONO,Amelio et al. (39) suggested that
NONO directly bridges interactions between RNA polymerase II
and other activators. Other groups have shown that NONO reg-
ulates nuclear retention of RNAs (40, 41) or transcription termi-
nation (42), so it is possible that NONO couples transcription
initiation and downstream RNA processing.
NONO itself is not expressed in circadian fashion. Nevertheless,
it binds to PER proteins and has been shown to antagonize their
repressive activity (12). Recently, a protein highly homologous to
NONO called splicing factor, proline- and glutamine-rich (SFPQ)
has been shown to bind to PER proteins as well, but to assist in
their repressive activity by recruiting the mSIN3A histone deace-
tylase (43). Consistent with these results, we have previously
demonstrated that all three members of the DBHS protein family
[Drosophila Behavior Human Splicing, of which NONO, SFPQ,
and paraspeckle component 1 (PSPC1) are members] likely play
redundant roles via cis-acting E-box elements at circadian genes
(22). Here we show that NONO plays a strong activating role, also
circadian, at the p16-Ink4A promoter. However, this activation is
dependent upon a particular 175-bp sequence within the promoter
region of this gene that does not contain an E-box. Thus, multiple
sequences likely direct activities of DBHS proteins, and these can
be activating or repressing. DBHS proteins themselves seem to
have no sequence-speciﬁc DNA-binding activity, although struc-
ture-speciﬁc binding (DNA triplexes, RNA loops) has been pos-
tulated (44, 45). We propose that NONO and homologous factors
might act as circadian output effectors, linking circadian regulation
via PER proteins to activating and repressing moities to confer
circadian expression upon diverse aspects of physiology and gene
expression. The exact mechanism of this regulation will doubtless
constitute a fascinating subject of future investigations.
NONO as a Link Between the Circadian Clock and the Cell Cycle. In
keeping with NONO’s proposed role as a circadian output effector,
we present here data that show that NONO directly activates the
p16-INK4A cell cycle checkpoint gene in circadian fashion to reg-
ulate cell cycle progression. Multiple circadian inﬂuences upon the
cell cycle have already been documented, acting at multiple dif-
ferent checkpoints. For example, it has been suggested that tran-
scriptional control of cell cycle genes such as p21-waf1 and wee1
might play important roles. BothWee1 transcript and protein levels
show circadian ﬂuctuation probably governed by cis-acting E-box
elements, and one of the targets of the WEE1 kinase, CDC2, also
shows circadian phosphorylation (3). A similar story has been
constructed for p21-waf1,whose circadian transcription is governed
by REV-ERBα response element (RRE) elements within the
promoter that respond to REV-ERBα/β and retinoid-related or-
phan receptor (ROR) proteins (17). Another class of clock factors,
the PER proteins, themselves function as tumor suppressors (46,
47). Similarly, TIM—shown by some groups to play a role in the
mammalian circadian clock (48)—has been shown to bind to the
CHK1 and CHK2 cell cycle proteins (19). Thus, in total, ﬁve dif-
ferent sites of action of the circadian clock upon the cell cycle have
been proposed. One of the principal difﬁculties in evaluating the
roles of these independent mechanisms in different tissues lies in
the importance of cell cycle checkpoint proteins, which precludes
meaningful loss-of-function experiments. What is particularly in-
teresting about NONO is that its disruption completely abrogates
circadian gating of the cell cycle in ﬁbroblasts without severely
disrupting either the circadian clock or the cell cycle. Importantly
for our conclusions about circadian regulation of the cell cycle, even
if the NONOhomolog NON-A is essential for circadian function in
ﬂies (12), NONO-deﬁcient mice possess essentially normal clocks
in all tissues examined. This discrepancy likely arises because of
functional redundancy between NONO and homologous proteins
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Fig. 5. NONO protein is necessary for circadian gating of the cell cycle in
primary ﬁbroblasts. Dividing primary ﬁbroblasts were clock-synchronized
with dexamethasone and then harvested at different times of day, ﬁxed, and
stained with propidium iodide. The percentage of dividing cells (i.e., in S
phase) from (A) WT, (B) per1/per2mut, and (C) Nonogt cultures was then
quantiﬁed by FACS analysis. (Times indicated are relative to synchronization.)
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Fig. 6. NONO protein is necessary for correct dermal wound healing. (A) WT
and Nonogtmice were incisionally wounded and then killed 3, 7, or 20 d later.
Representative Masson-Goldner trichrome-stained parafﬁn sections from the
center of these wounds are shown. (B) Wound healing subscores of normal
healing WT mice compared with Nonogt mice on day 3, 7, 13, and 20 after
incisional wounding in the dorsal skinfold. Data represent means ± SD (n = 5).
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SFPQ and PSPC1 within the circadian oscillator in mammals (22).
Thus, the Nonogt mouse provides a mouse model in which the cell
cycle is uncoupled from a functional circadian clock.
Circadian Control and Wound Repair. Because Nonogt ﬁbroblasts
show increased proliferation and decreased senescence, it is
perhaps to be expected that dermal wound repair is disrupted
in Nonogt animals. Nevertheless, because collagen is secreted
by ﬁbroblasts, a dramatic lack of collagen in wounds in Nonogt
animals is not what we anticipated in the ﬁbroblast-hyper-
proliferated wounds of these animals. It might hint, however, at
the underlying function of the gating of the cell cycle by NONO.
We hypothesize that regulated cell division might allow for orga-
nized cycles of division and tissue building and thereby facilitate
the organization of complex tissue structures. By contrast, when
cell division occurs constantly and randomly, such organization
never occurs, resulting in the overproliferation and under-epithe-
lialization we have observed. Our argument is supported by the
fact that two different types of circadian clock-deﬁcient animals
(bmal1−/−mice and per1/per2mutmice) also show defects in wound
healing. The requirement for clocks in wound healing seems to be
conserved in other vertebrates: very recently, a role for the circa-
dian clock in zebraﬁsh ﬁn healing was also documented (49).Other
recent research points to a network of clock and clock-controlled
genes whose expression is important for proliferation of ﬁbroblasts
and keratinocytes, including the clock genes Clock (5) and Bmal1
(6) and the circadian output effector Klf9 (7). Hence the effects
that we observe are unlikely to be caused by an activity of the
NONO protein unrelated to the circadian clock. The loosely
“opposite” phenotypes of different circadian mutant mice further
support the idea that circadian gating per se is important for der-
mal healing. Bmal1−/−mice, defective in the “positive limb” of the
circadian oscillator, show excessive ﬁbrin with reduced ﬁbroblast
number; and per1/per2mut mice defective in the “negative limb”
show increased ﬁbroblasts and reduced ﬁbrin.
Of course, correct wound healing is not simply a matter of cell
division but also of differentiation. Prekeratinocyte and other
stem cells ﬁrst augment in number and then differentiate to their
ﬁnal nonproliferative types. It has been suggested that the cir-
cadian clock in hair root follicles plays an important role in
generating heterogenous populations of cells necessary for hair
growth (50), and a similar role in skin regeneration is not only
possible, but to the authors likely. Through its role in replicative
senescence, the p16-INK4A protein plays a key role in mesen-
chymal stem cell differentiation (51), so it is possible that cir-
cadian regulation of this protein via NONO would affect not only
cell division but also stem cell populations. However, these
processes are unseparable and intertwined: our observation of
overproliferation of keratinocytes at wounds in Nonogt animals
also implies an overrepresentation of prekeratinocyte stem cells
at these times, and the overproliferation of ﬁbroblasts equally
shows direct control of cell division itself. The key to both
observations—and also the key conclusion of this study—is that
circadian control of the p16-INK4A checkpoint via NONO is
necessary for correct dermal wound healing, and lack of this
control results in loss of circadian cell cycle gating in vitro and
tissue overproliferation in vivo. The exact downstream mecha-
nism of this control and its consequences for tissue structure will
provide a fascinating and medically relevant subject for future
investigations. It should be noted, however, that tissue formation
during development in both Nonogt and clock-disrupted mice
seems normal. Therefore, it is likely that such control is either
unnecessary or redundant earlier in development.
Asmore is known about the feedback loops that control circadian
clock mechanism, increasing numbers of laboratories have begun
to address the questions of how and why the circadian oscillator
communicates timing to all of the physiological and cellular process
that it governs. In these studies a pattern has begun to emerge: basic
clock components can themselves directly regulate genes involved
in the “output pathways” that control diurnal function (52). In
this article we show that the NONO protein plays an essential in-
termediary role. More generally, coopting the circadian clock as
a synchronizing timekeeper—completely independent of its role in
diurnal adaptation—might provide an important future paradigm
for clock function at a cellular level.
Materials and Methods
Plasmids. The bioluminescence reporter construct pBmal1-Luciferase and the
NONO-targeting siRNA6 have been described previously (12). For NONO
overexpression, a commercially obtained pSPORT construct was used (clone
ID 360A935 from Open Biosystems). p16-promoter-luciferase plasmid (D-761)
and minimal p16 promoter plasmid (D-141) (53) were obtained from B. A.
Mock and S. Zhang (Laboratory of Genetics, Center for Cancer Research,
National Cancer Institute, National Institutes of Health, Bethesda, MD).
Animal Husbandry. Chimeric mice were obtained from Nonogt ES cells (C57Bl6
genotype) via standard blastocyst injection into SV129 mice by the University
of California, Davis. Individual chimeric mice were back-crossed 4–10 gen-
erations against C57Bl6. All experiments were performed with littermates.
Animal housing and experimental procedures are in agreement with vet-
erinary law of the canton of Zurich. Genotyping was done as described at
www.mmrrc.org/strains/38/ctr_protocol.pdf using a NONO-speciﬁc primer
set (sense 5′-TTA GGG GGC CGA ACT ACT TGA ATT G-3′, antisense 5′-GGG
CCG GGC AGA TTT ACT AGT TTT T-3′. Quantitative PCR (qPCR) primer
sequences are listed in the quantitative real-time PCR section, below).
Primary Cell Isolation and Culture. Primaryadult dermalﬁbroblasts (ADFs)were
taken from a 0.5-cmpiece ofmouse tail thatwas cut into several small pieces by
usinga razorblade.Digestionoccurred in1.8mLDMEMcontaining20%FBS,1%
penicillin/streptomycin, and 1% amphotericin B supplemented with 0.7 U Lib-
erase blendzyme (Roche), at 37 °Cand 5%CO2 for 8h (all concentrations are vol/
vol). After centrifugation in 1× PBS, the pellet was resuspended in DMEM
containing20%FBS, 100U/mLpenicillin, 100 μg/mL streptomycin, and2.5 μg/mL
amphotericin B and kept at 37 °C and 5% CO2. The next day, medium was ex-
changed, and remaining tail pieces were removed. Another medium exchange
was done 3 d later. After 1wk themediumwas exchanged formediumwithout
amphotericin B. Subsequently, ADFs were cultured at 37 °C and 5% CO2 in
DMEM supplemented with 20% FBS and 1% penicillin/streptomycin.
cDNA Production, Quantitative Real-Time PCR, and PCR Arrays. RNA was
extracted as described in (12). Five hundred nanograms of total RNA was
transcribed to cDNA with SuperScript II (Invitrogen) using oligo (dT) primers
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Fig. 7. Functional circadian clock is necessary for correct dermal wound
healing. (A) Masson-Goldner trichrome staining of 6-d wounds from WT
(Left), per1/per2mut (Center), and bmal1−/− mice (Right). D, dermis; E, epi-
dermis; Es, Eschar; F, ﬁbrin; FH, ﬁbroblast hyperproliferation; G, granulation
tissue; He, hemorrhage; HE, hyperproliferative epithelium; HF, hair follicle.
(Scale bar, 1 mm.) (B) Wound healing subscores of normal healing WT mice
compared with per1/per2mut and bmal1−/− mice on day 6 after incisional
wounding in the dorsal skinfold. Data represent means ± SD (n = 6).
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according to the manufacturer’s instructions. For quantitative real-time PCR
20 ng of cDNA was used, and transcript levels of genes were detected by
Taqman probes used with the Taqman PCR mix protocol (Roche) using the
AB7900 thermocycler. Primers used for detection of speciﬁc genes are listed
in Table S2. PCR arrays to quantify cell cycle components were performed
according to the manufacturer’s instructions using 500 ng of total RNA
(SABiosciences; array name, PAMM-020E). RNA was extracted from duplicate
plates of either WT or Nonogt primary ﬁbroblasts 14 d after isolation.
Western Blotting and Immunohistochemistry. Western blotting was per-
formed using standard procedures (Current Protocols in Molecular Bi-
ology, Wiley). Equal loading and size detection using protein ladder was
veriﬁed by Ponceau-S staining of membranes before probing. The
probing of the primary anti-NONO antibody (polyclonal antibody raised
by Charles River Labs using bacterially produced NONO protein, afﬁnity-
puriﬁed against the antigen used for injection) was done at a 1:200 di-
lution. The probing of the secondary antibody was done at a 1:10,000
dilution for anti-rabbit IgG coupled to horseradish peroxidase (Sigma)
and 1:1,000 for anti-mouse HRP (Sigma), respectively.
Cellular Senescence and Cytometric Measurements. For growth curves, primary
ﬁbroblasts from WT and Nonogt animals were split every other day, plating
each time 1 × 106 cells so that conﬂuence was never reached. Within these
plates, a coverslip was laid for senescence-associated β-galactosidase stain-
ing, and nonplated cells were saved for RNA isolation. Population doublings
were calculated as the logarithm of the number of cells counted at the
current passage divided by the number of cells at the ﬁrst passage, adjusted
for plating ratios. Senescence-associated β-galactosidase staining was per-
formed using a senescence β-galactosidase Staining Kit (Cell Signaling
Technology) following the protocol of the manufacturer.
Tomeasurecell cycleprogressionatdifferentcircadiantimes, circadianclocks
in identical plates of WT and Nonogt primary ﬁbroblasts were synchronized
with 100 nM dexamethasone for 30 min as previously described (32) at day 10
of serial splitting. Seven hours after synchronization cells from duplicate plates
were ﬁxed every 4 h. Fixation and ﬂow cytometric measurements of DNA
content via propidium iodide staining were performed according to Current
Protocols in Cell Biology, chapter 8.4.4 (54). Cell cycle stages were quantiﬁed
using the Watson cell cycle model of the FlowJo software.
For EdU pulse labeling the commercially available Click-iT EdU Alexa Fluor
647 Flow Cytometry Assay Kit from Invitrogen was used, following the
manufacturer’s instructions. Flow cytometry data were analyzed with the
FlowJo software package.
For CFSE staining, cells were trypsinized, resuspended in complete cell
medium, and then washed with 1× PBS. From this, 1 × 106 cells were trans-
ferred and spun down. The pellet of cells was then resuspended in 0.2 mL 1×
PBS supplemented with 5 μM CFSE and incubated for 10 min at 37 °C. By
adding ice-cold complete cell medium the reaction was stopped and the cells
were washed with 1× PBS. The pellet of cells was resuspended in complete
cell medium, plated, and allowed to grow until analysis. These cells were
compared with a plate that was mitomycin C treated to arrest cell division
and then stained in the same way as described above with CFSE. In brief,
10 mL of a 10 μg/mL mitomycin C (SIGMA, M4287) solution were added to
a 10-cm dish of cells and incubated for 3 h at 37 °C with 5% CO2. Afterward
cells were washed three times with 1× PBS supplemented with 5% of FBS and
then normal growth medium was added and cells were incubated overnight.
The next day the plate was split 1:1 to remove dead cells and cell debris, and
then CFSE treated as above. After 4 d both arrested and dividing cells were
trypsinized, washed three times with 1× PBS, and then resuspended in 1× PBS
supplemented with 1% FBS for FCSE measurement using a BD FacsCanto
II machine.
Transient Transfections. For p16Ink4A reporter transfection studies Lipofect-
amine LTX with PLUS reagent (Invitrogen) was used according to the manu-
facturer’s instructions, cultivating cells in 24-well plates and transfecting them
with a total of 650 ng DNA, of which 50 ng were the promoter luciferase
reporter construct. Varying amounts of pCMV-NONO plasmid were “bal-
anced” by the addition of pKS(+) to a total of 600 ng. Cells were harvested
after 60 h by washing once with 1× PBS and extracting with the supplied
buffer from a luciferase assay kit (Promega). Quantiﬁcation was done by
scintillation counting, and normalized against total protein amount.
ChIP. Chromatin from mouse liver and tissue culture cells was obtained as
described previously (55). Equal amounts of precleared chromatin were in-
cubated overnight at 4 °C with 1 μL of anti-NONO antibody or anti-PER2
antibody. The capture of the DNA:protein complexes, the washing con-
ditions, and the puriﬁction of the DNA fragments before qPCR, as well the
control antibodies have been described previously (56). The region-speciﬁc
primer/probe pairs are listed in Table S2.
Histological Wound Scoring.WT and Nonogt mice were anesthetized i.p. with
a mixture of 90 mg/kg body weight (BW) ketamine hydrochloride (Ketavet;
Parke Davis) and 25 mg/kg BW xylazine hydrochloride (Rompun; Bayer). The
dorsal region was shaved and treated with a depilatory agent (Pilca Perfect;
Stafford-Miller Continental). Three full-thickness incisions (6 mm) perpen-
dicular to the dorsal midline were made at one anterior and two posterior
dorsal sites, and the skin margins were closed with Steri-Strips (Steri-Strip
S Surgical Skin Closure; 3M). Mice were killed on day 3, 7, 13, and 20 after
wounding and the wounds embedded according to standard procedures
and stained with Masson-Goldner trichrome and hematoxylin eosin. A total
of 16 animals (8 WT and 8 NONOgt, n = 2 for each timepoint) were wounded
and killed on the corresponding time points, and two additional WT and
NONOgt mice without any incisions served as controls. Subsequently, iden-
tical experiments were performed on three each of WT, bmal1−/−, and per1/
per2mut mice, with killing on day 6 after wounding. Histological wound
scoring has been described previously (57) and was based on the quality of
dermal organization, epidermal regeneration, collagen deposition, cellular
content, and wound vascularity. The criteria used as histological scores of
wound healing are summarized in Table S3.
Statistical Methods. In bar graphs, Student’s t test was used to determine
signiﬁcant differences between control and experimental groups. In all
ﬁgures, n = 3–4 independent experiments, with each experiment conducted
in technical duplicate. Data are plotted ±SEM. In line graphs, for each ex-
perimental data set, linear regression was conducted to determine best-ﬁt
line describing the data from each independent experiment. Overall sig-
niﬁcance of differences in doubling (e.g., Fig. 1A) or in accumulation rate
(e.g., Fig. 2A) were then determined using a Student two-tailed t test of
slopes of the regression lines from each data set (n = 2–4).
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Fig. S1. Transcription of senescence-implicated genes in serially passaged WT and Nonogt primary ﬁbroblasts. WT and Nonogt primary ﬁbroblasts were
counted and passaged every 2 d and a constant number of cells plated to a new dish. Total RNA was harvested from cells in each passage, and quantitative PCR
(qPCR) was used to quantify the transcript levels of senescence-implicated genes tankyrase (A) and p53 (B), as well as upstream regulators of p16-Ink4A, the
genes Id1 (C), Ets1 (D), and Ets2 (E). Values are plotted in arbitrary units relative to WT levels at passage 1.

ht
tp
://
do
c.
re
ro
.c
h
AB
120
100
80
60
40
20
0
1.8
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0
Control shRNA pSPORT-
Nono NONO
Control shRNA pSPORT-
Nono NONO
Lu
ci
fe
ra
se
ac
tiv
ity
Lu
ci
fe
ra
se
ac
tiv
ity
Fig. S2. NONO activates transcription of p16-Ink4A promoter reporters. (A) Relative expression levels of the diagrammed p16-luc promoter construct alone, in
the presence of a NONO-targeting RNAi hairpin that reduces NONO levels 10-fold, and in the presence of a NONO-overexpressing vector. (B) Similar ex-
periments using the diagrammed construct containing the p16-Ink4A 3′ UTR.
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Fig. S3. Dermal structure and incisional wound healing in WT and Nonogt mice. (A) H&E-stained parafﬁn sections from uninjured dorsal skin. Normal skin
morphogenesis is not affected in Nonogt mice compared with WT littermates (10–11 wk of age, 24 g body weight). (B) Full wound healing subscores of normal
healing WT mice compared with Nonogt mice on day 3, 7, 13, and 20 after incisional wounding in the dorsal skinfold. Data represent means ± SD (n = 5).
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Table S1. Regulation of cell cycle genes in WT and Nonogt
ﬁbroblasts
Gene Fold difference, gt/WT
Abl1 2.11
Ak1 3.90
Apbb1 1.91
Atm 2.14
Brca1 3.09
Brca2 3.56
Camk2a 2.18
Camk2b 0.37
Casp3 2.67
Ccna1 0.37
Ccna2 19.68
Ccnb1 27.08
Ccnb2 10.26
Ccnc 5.27
Ccnd1 6.05
Ccne1 2.83
Ccnf 5.21
Cdc25a 2.58
Cdk2 12.98
Cdk4 4.51
Cdk5rap1 2.78
Cdkn1a 1.57
Cdkn1b 3.44
Cdkn2arf 1.85
Chek1 3.31
Cks1b 2.37
Ddit3 3.07
Dnajc2 1.73
Dst 1.12
E2f1 1.64
E2f2 0.37
E2f3 6.78
E2f4 1.70
Gadd45a 3.13
Gpr132 0.37
Hus1 3.04
Inha 0.82
Itgb1 1.81
Macf1 2.72
Mad2l1 2.93
Mcm2 7.62
Mcm3 9.82
Mcm4 5.67
Mdm2 2.94
Mki67 5.58
Mre11a 1.16
Msh2 1.57
Mtbp 4.46
Myb 0.17
Nek2 3.11
Nfatc1 2.82
Notch2 4.04
Npm2 1.06
Pcna 3.95
Pes1 2.48
Pkd1 1.93
Pmp22 1.74
Ppm1d 2.03
Ppp2r3a 0.90
Ppp3ca 1.86
Prm1 0.37
Rad17 3.17
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Table S1. Cont.
Gene Fold difference, gt/WT
Rad21 2.38
Rad51 0.43
Rad9 2.66
Ran 3.18
Rbl1 0.94
Rbl2 1.04
Sesn2 1.53
Sfn 2.05
Shc1 5.39
Skp2 3.24
Slfn1 0.37
Smc1a 5.86
Stag1 3.45
Sumo1 3.45
Taf10 3.08
Terf1 2.62
Tfdp1 3.53
Psmg2 2.74
Trp53 3.18
Trp63 0.15
Tsg101 1.25
Wee1 1.23
Gusb 5.23
Hprt1 0.01
Hsp90ab1 3.04
Gapdh 2.53
Actb 2.77
Total RNA was harvested from dividing cultures of WT and Nonogt pri-
mary ﬁbroblasts and subjected to qPCR array analysis. All array targets are
shown, with fold-regulation of Nonogt vs. WT ﬁbroblasts. Note that the p16-
Ink4A transcript itself was not probed on this commercial array. Independent
qPCR analysis using the primers in Table S2 conﬁrmed ﬁvefold reduction in
expression of p16-Ink4A in Nonogt vs. WT ﬁbroblasts in both replicates of the
cellular RNA used for this array.
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Table S2. Primer sequences
Gene Orientation Sequence (5′–3′)
Ets1 Sense CGG CAT CAT AGC ACA GTT CAA G
Ets1 Antisense CCC ATG CAA ACG GCT TTT AT
Ets1 Probe FAM-AAC CGC TAC CCG AAA CAT GGA AGA CTC
AG-TAMRA
Id1 Primer Set 1) Assay lD: Mm00775963_g1
Ets2 Primer Set 1) Assay lD: Mm00468972_m1
NONO Sense TGC GCT TCG CCT GTC A
NONO Antisense GCA GTT CGT TCG ACA GTA CTG
NONO Probe FAM-AGT GCA CCC TTA CAG TCC GCA ACC
TT-TAMRA
qPCR
p16-Ink4A Sense CCC AAC GCC CCG AAC T
p16-Ink4A Antisense GTG AAC GTT GCC CAT CAT CA
p16-Ink4A Probe FAM-TTT CGG TCG TAC CCC GAT TCA GG-TAMRA
ChIP
p16-Ink4A Sense TTT CGC CCA ACG CCC CGA A
p16-Ink4A Antisense ACC CGA CTG CAG ATG GGA CAC
p16-Ink4A Probe FAM- CGA ACT CTT TCG GTC GTA CCC CGA
TTC-TAMRA
p53 Sense GCA TCC CGT CCC CAT CA
p53 Antisense GGA TTG TGT CTC AGC CCT GAA G
p53 Probe FAM-CAG CCT CCC CCT CTC CTT GCT GTC
TTA-TAMRA
Tankyrase Sense CGG CAG CAG AGC AGA AGA C
Tankyrase Antisense TGT ACT CCA GTT GCA GGT TTG AAT
Tankyrase Probe TAG TGA CCA CCC CTG GTA AAG GCC AGA-TAMRA
GAPDH Sense CAT GGC CTT CCG TGT TCC TA
GAPDH Antisense CCT GCT TCA CCA CCT TCT TGA
GAPDH Probe YAK-CCG CCT GGA GAA ACC TGC CAA GTA
TG-TAMRA
TaqMan Gene Expression Assays from Applied Biosystems are tested, but sequences are not provided. Assay
consists of primer forward, primer reverse, and probe, as usual.
Table S3. Histological wound healing scores
Score
Dermal
organization
Epidermal
regeneration
Collagen
deposition
Cellular
content
Wound
vascularity
1 25% thickness of granulation
tissuecompared with
healthy tissue
No epithelial closure Gap without ingrowing
collagen ﬁbrils
Low cell proliferation,
mainly inﬂammatory cells
1–3 capillaries
per visual ﬁeld
2 50% thickness of granulation
tissuecompared with
healthy tissue
Strong hyperproliferative
epithelium
Gap with ingrowing
collagen ﬁbrils
Predominantly inﬂammatory
cells or dysfunctional ﬁbroblasts,
hyper-proliferation
4–6 capillaries
per visual ﬁeld
3 75% thickness of granulation
tissuecompared with
healthy tissue
Moderate hyperproliferative
epithelium
No gap, but unstable
adhesion
Predominantly normal
ﬁbroblasts
7–9 capillaries
per visual ﬁeld
4 Thickness of granulation
tissue equal to healthy
tissue
Thickness and structure
equal to normal
epithelium
No gap, stable
adhesion
Low cell proliferation,
mainly ﬁbroblasts
>9 capillaries
per visual ﬁeld
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